Johnson & Johnson
- JNJ
- Famous companies
- Latest: Q3 2026
- Ended Sep 27, 2026
- Reported Oct 21, 2026
- Revenue
- $25.4B
- +5.9% vs $24.0B a year ago
- Profit (net income)
- $210M
- $5.2B a year ago
- Profit margin
- 0.8%
- Profit per $1 of sales
- EPS (diluted)
- $0.09
- −95.8% vs $2.12 a year ago
- Operating income
- Not reported
- Profit from the core business
- Cash
- $16.9B
- On Sep 27, 2026
- Long-term debt
- $35.8B
- Long-term debt, noncurrent portion
- Dividend per share
- $1.34
- 2,407M shares outstanding
The last 8 quarters
Newest first. Changes compare with the same quarter a year earlier.
| Quarter | Revenue | vs year ago | Profit | Margin | EPS | vs year ago | Operating income | Cash | Long-term debt | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2026Ended Sep 27, 2026 | $25.4B | +5.9% | $210M | 0.8% | $0.09 | −95.8% | — | $16.9B | $35.8B | 10-Q for Q3 2026 on SEC EDGAR (opens in a new tab)Oct 21, 2026 |
| Q2 2026Ended Jun 28, 2026 | $25.3B | +6.6% | $5.5B | 21.9% | $2.27 | −0.9% | — | $20.4B | $37.3B | 10-Q for Q2 2026 on SEC EDGAR (opens in a new tab)Jul 23, 2026 |
| Q1 2026Ended Mar 29, 2026 | $24.1B | +9.9% | $5.2B | 21.8% | $2.14 | −52.9% | — | $21.7B | $37.5B | 10-Q for Q1 2026 on SEC EDGAR (opens in a new tab)Apr 22, 2026 |
| Q4 2025Ended Dec 28, 2025 | $24.6B* | +9.1% | $5.1B* | 20.8% | $2.09* | +48.2% | — | $19.7B | $39.4B | 10-K for Q4 2025 on SEC EDGAR (opens in a new tab)Feb 11, 2026 |
| Q3 2025Ended Sep 28, 2025 | $24.0B | +6.8% | $5.2B | 21.5% | $2.12 | +91.0% | — | $18.2B | $39.4B | 10-Q for Q3 2025 on SEC EDGAR (opens in a new tab)Oct 22, 2025 |
| Q2 2025Ended Jun 29, 2025 | $23.7B | +5.8% | $5.5B | 23.3% | $2.29 | +18.6% | — | $18.6B | $39.2B | 10-Q for Q2 2025 on SEC EDGAR (opens in a new tab)Jul 24, 2025 |
| Q1 2025Ended Mar 30, 2025 | $21.9B | +2.4% | $11.0B | 50.2% | $4.54 | +238.8% | — | $38.5B | $38.4B | 10-Q for Q1 2025 on SEC EDGAR (opens in a new tab)Apr 23, 2025 |
| Q4 2024Ended Dec 29, 2024 | $22.5B* | +5.3% | $3.4B* | 15.2% | $1.41* | −15.6% | — | $24.1B | $30.7B | 10-K for Q4 2024 on SEC EDGAR (opens in a new tab)Feb 13, 2025 |
“—” means not reported in the filing, or (for changes) no fair comparison because the year-ago figure was zero or a loss. * Derived: the full year (or year to date) minus the earlier quarters, because the company reported this quarter only inside a longer period.
SEC filings behind these numbers
- 10-Q · Q3 2026Filed Oct 21, 2026 · 0000200406-26-000197(opens SEC EDGAR in a new tab)
- 10-Q · Q2 2026Filed Jul 23, 2026 · 0000200406-26-000153(opens SEC EDGAR in a new tab)
- 10-Q · Q1 2026Filed Apr 22, 2026 · 0000200406-26-000087(opens SEC EDGAR in a new tab)
- 10-K · Q4 2025Filed Feb 11, 2026 · 0000200406-26-000016(opens SEC EDGAR in a new tab)
- 10-Q · Q3 2025Filed Oct 22, 2025 · 0000200406-25-000209(opens SEC EDGAR in a new tab)
- 10-Q · Q2 2025Filed Jul 24, 2025 · 0000200406-25-000178(opens SEC EDGAR in a new tab)
- 10-Q · Q1 2025Filed Apr 23, 2025 · 0000200406-25-000119(opens SEC EDGAR in a new tab)
- 10-K · Q4 2024Filed Feb 13, 2025 · 0000200406-25-000038(opens SEC EDGAR in a new tab)
Follow Johnson & Johnson
We'll email you the headline numbers when Johnson & Johnson files its next quarter.
More famous companies
Figures are as JOHNSON & JOHNSON tagged them in its 10-Q and 10-K filings, in its own fiscal quarters. Revenue here is revenue from customers; profit is net income attributable to the company; EPS is diluted earnings per share. Restated quarters show the latest filed figure. Cash and debt are as of each quarter's last day (debt: long-term debt, noncurrent portion).
No stock prices or valuations. Not investment advice, and a listing here is not a recommendation to buy or sell any security.
Source: SEC EDGAR, company 10-Q and 10-K filings (XBRL) · As of Nov 4, 2026